Skip to content

Impact of Bariatric Surgery in Patients With Morbid Obesity

Impact of Bariatric Surgery in Patients With Morbid Obesity. Prospective Study With Comparison Before and After

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04009356
Acronym
IVBIA
Enrollment
300
Registered
2019-07-05
Start date
2020-01-22
Completion date
2022-01-01
Last updated
2022-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anal Incontinence, Image, Body, Obesity, Morbid

Brief summary

The main objective is to compare the prevalence of anal incontinence (AI) before and after bariatric surgery in obese patients. Inclusion: Patients who are scheduled for a bariatric surgical procedure after a multidisciplinary evaluation for about 1 year (following french national recommendations). Primary objective: After inclusion, all patients will fill in a specific self-questionnaire evaluating AI (PFDI-20 score) before surgery and at 6 months after surgery. Investigators will evaluate the prevalence of anal incontinence before and at 6months after surgery using this PFDI- 20 score. In those patients with preoperative anal incontinence (only in patients with 3 positive answers to question n°9,10, and 11 of PFDI-20 score self-questionnaire), a pelvic MRI will be performed before and at 6 months after surgery. Consequently, no further imaging exam will be performed in patients without preoperative anal incontinence (less than 3 positive answers to question n°9,10, and 11), Secondary objectives: * to evaluate the AI severity variation before and at 6 months after bariatric surgery regarding the percentage of postoperative weight loss. * to compare the quality of life (PFIQ-7 score) related to AI day before and at 6 months after bariatric surgery.

Detailed description

This study is proposed to all obese patients evaluated for potential bariatric surgery during a multidisciplinary evaluation for about 1 year following current french national recommendations. Demographics are collected from medical records (age, sex, weight, height, diabetes, sleep apnea syndrome, hypertension, lipid disorders, distal neuropathy, depression, number of pregnancies, history of vaginal delivery, traumatic delivery, caesarean section, hysterectomy, urinary incontinence surgery, proctologic surgery, presence of rectal prolapse (operated or not), cholecystectomy, digestive resection, menopause, history of urinary or fecal or gaseous leakage, current treatments, tobacco consumption, diet. Data are collected by self-questionnaire to all included patient during the preoperative consultation (about 6 weeks before bariatric surgery) and during the 6-months postoperative clinical visit scheduled during the regular follow-up.

Interventions

PROCEDUREbariatric surgical procedures

gastric bypass, sleeve, banding,biliopancreatic diversion

Sponsors

Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* BMI\>40 kg/m2 * BMI\> 35 kg/m2 with comorbidity ( high blood pressure, diabetes, dyslipidemia, sleep apnea syndrome)

Exclusion criteria

* anal incontinence due to chronic diarrhea * transit constipation * peripheral neuropathy (diabetes ...) * patient opposition * any previous bariatric surgical procedure * any pelvic surgical procedure performed during the study period (between preoperative and postoperative period at 6 months)

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of anal incontinence before and after bariatric surgery (%)at 6 month postoperativelyPFDI-20 score (pelvic floor distress inventory) from zero to 12 (0: no incontinence and 12: severe incontinence)

Secondary

MeasureTime frameDescription
Severity of anal incontinence before and after surgery (score)at 6 month postoperativelyPFDI-20 score (pelvic floor distress inventory) from zero to 12 (0: no incontinence and 12: severe incontinence)
quality of life related to anal incontinence (score)at 6 month postoperativelyPFIQ-7 (pelvic floor impact questionnaire) from 0 to 16 (0: no incontinence and 16: severe incontinence)
Pelvic imaging (MRI)before and at 6 month postoperativelyMRI

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026